{"title":"The surgical management of primary hyperparathyroidism: an updated review","authors":"Kaela E Parnell, Sarah C. Oltmann","doi":"10.2217/IJE-2017-0019","DOIUrl":"https://doi.org/10.2217/IJE-2017-0019","url":null,"abstract":"","PeriodicalId":42691,"journal":{"name":"International Journal of Endocrine Oncology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/IJE-2017-0019","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48074809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sara Donato1, Rita Santos1,2, Helder Simões1,2 & Valeriano Leite*,1,2,3 1Endocrinology Department, Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisbon, Portugal 2NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal 3Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisbon, Portugal *Author for correspondence: vleite@ipolisboa.min-saude.pt
Sara Donato1，Rita Santos1,2，Helder Simões1,2&Valeriano Leite*，1,2,3 1里斯本肿瘤研究所肿瘤系，Francisco Gentil，里斯本，葡萄牙2里斯本新里斯本大学医学院/医学院，Francisco Gentil，葡萄牙里斯本*通信作者：vleite@ipolisboa.min-saude.pt
{"title":"Novel therapies against aggressive differentiated thyroid carcinomas","authors":"S. Donato, Rita Santos, H. Simões, V. Leite","doi":"10.2217/IJE-2017-0022","DOIUrl":"https://doi.org/10.2217/IJE-2017-0022","url":null,"abstract":"Sara Donato1, Rita Santos1,2, Helder Simões1,2 & Valeriano Leite*,1,2,3 1Endocrinology Department, Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisbon, Portugal 2NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal 3Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisbon, Portugal *Author for correspondence: vleite@ipolisboa.min-saude.pt","PeriodicalId":42691,"journal":{"name":"International Journal of Endocrine Oncology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/IJE-2017-0022","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43365863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kimberly J Kiplagat, M. Griffin, F. Baik, Abraham D Minkowitz, M. Urken
{"title":"Thyroid Care Collaborative: an electronic health record facilitating multidisciplinary management of thyroid cancer","authors":"Kimberly J Kiplagat, M. Griffin, F. Baik, Abraham D Minkowitz, M. Urken","doi":"10.2217/IJE-2017-0027","DOIUrl":"https://doi.org/10.2217/IJE-2017-0027","url":null,"abstract":"","PeriodicalId":42691,"journal":{"name":"International Journal of Endocrine Oncology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2018-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/IJE-2017-0027","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47906824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Patience Green, R. Schwartz, J. Shell, Michael Allgauer, Daniel Chong, E. Kebebew
{"title":"Exceptional response to vemurafenib and cobimetinib in anaplastic thyroid cancer 40 years after treatment for papillary thyroid cancer","authors":"Patience Green, R. Schwartz, J. Shell, Michael Allgauer, Daniel Chong, E. Kebebew","doi":"10.2217/IJE-2017-0016","DOIUrl":"https://doi.org/10.2217/IJE-2017-0016","url":null,"abstract":"","PeriodicalId":42691,"journal":{"name":"International Journal of Endocrine Oncology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/IJE-2017-0016","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48495241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Gastroenteropancreatic neuroendocrine tumors and the NETTER-1 trial","authors":"M. Caplin","doi":"10.2217/IJE-2017-0023","DOIUrl":"https://doi.org/10.2217/IJE-2017-0023","url":null,"abstract":"","PeriodicalId":42691,"journal":{"name":"International Journal of Endocrine Oncology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/IJE-2017-0023","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42102030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M Sara Rosenthal, Kenneth B Ain, P. Angelos, Ryoko Hatanaka, M. Motojima
{"title":"Problematic clinical trials in thyroid cancer: the issue of papillary carcinoma and observational approaches","authors":"M Sara Rosenthal, Kenneth B Ain, P. Angelos, Ryoko Hatanaka, M. Motojima","doi":"10.2217/IJE-2017-0008","DOIUrl":"https://doi.org/10.2217/IJE-2017-0008","url":null,"abstract":"","PeriodicalId":42691,"journal":{"name":"International Journal of Endocrine Oncology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2017-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/IJE-2017-0008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43459143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The long goodbye to glycine-extended peptide hormones","authors":"J. Rehfeld","doi":"10.2217/IJE-2017-0015","DOIUrl":"https://doi.org/10.2217/IJE-2017-0015","url":null,"abstract":"","PeriodicalId":42691,"journal":{"name":"International Journal of Endocrine Oncology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2017-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/IJE-2017-0015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42180169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pheochromocytoma and paraganglioma (PPGL) belong to the family of neural crest cell-derived neoplasms, and can be widely distributed throughout the body. Over the past few years, with respect to these tumors, precision medicine has offered the promise of improved patient care. Through tumor visualization and identification of molecular signatures, nuclear medicine is capable of playing a key role in PPGL precision medicine. 68Ga-labeled somatostatin analogs were found to improve the detection and staging of head and neck paragangliomas, SDHx-related PPGLs and metastatic PPGLs regardless of genetic background. For PPGLs associated with increased kinase signaling or HIF2A mutations, 18F-fluorodihydroxyphenylalanine appears to be the most informative radiopharmaceutical. This review emphasizes the current theranostic approaches and future perspective related to PPGL imaging options.
{"title":"Recent advances in the imaging of pheochromocytomas and paragangliomas","authors":"D. Taïeb, K. Wolf, K. Pacak","doi":"10.2217/IJE-2017-0004","DOIUrl":"https://doi.org/10.2217/IJE-2017-0004","url":null,"abstract":"Pheochromocytoma and paraganglioma (PPGL) belong to the family of neural crest cell-derived neoplasms, and can be widely distributed throughout the body. Over the past few years, with respect to these tumors, precision medicine has offered the promise of improved patient care. Through tumor visualization and identification of molecular signatures, nuclear medicine is capable of playing a key role in PPGL precision medicine. 68Ga-labeled somatostatin analogs were found to improve the detection and staging of head and neck paragangliomas, SDHx-related PPGLs and metastatic PPGLs regardless of genetic background. For PPGLs associated with increased kinase signaling or HIF2A mutations, 18F-fluorodihydroxyphenylalanine appears to be the most informative radiopharmaceutical. This review emphasizes the current theranostic approaches and future perspective related to PPGL imaging options.","PeriodicalId":42691,"journal":{"name":"International Journal of Endocrine Oncology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2017-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/IJE-2017-0004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43582210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Recent advances in medical therapies for pituitary adenomas","authors":"N. Tritos","doi":"10.2217/IJE-2017-0017","DOIUrl":"https://doi.org/10.2217/IJE-2017-0017","url":null,"abstract":"","PeriodicalId":42691,"journal":{"name":"International Journal of Endocrine Oncology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2017-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/IJE-2017-0017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45528114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The importance of grading and staging small intestinal neuroendocrine tumors","authors":"Raul S. Gonzalez, C. Shi","doi":"10.2217/IJE-2017-0009","DOIUrl":"https://doi.org/10.2217/IJE-2017-0009","url":null,"abstract":"","PeriodicalId":42691,"journal":{"name":"International Journal of Endocrine Oncology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2017-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/IJE-2017-0009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68217397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：